Medicine and Dentistry
Axilla
13%
Axillary Lymph Node
30%
Axillary Surgery
8%
Biopsy Technique
9%
Breast Cancer
100%
Diseases
35%
Epidermal Growth Factor Receptor 2
8%
Estrogen Receptor
8%
False Negative Result
10%
Gamma Urogastrone
8%
Hormone Receptor
7%
Intraductal Carcinoma
11%
Local Therapy
9%
Lumpectomy
6%
Lymph Node
12%
Malignant Neoplasm
11%
Mastectomy
22%
Metastatic Carcinoma
11%
Multivariate Analysis
6%
Neoadjuvant Chemotherapy
53%
Neoadjuvant Therapy
7%
Neoplasm
17%
Odds Ratio
8%
Oncology
13%
Overall Survival
5%
Quadrantectomy
20%
Quality of Life
5%
Radiation Therapy
17%
Recurrent Disease
15%
Retroperitoneal Lymph Node Dissection
44%
Sentinel Lymph Node
33%
Sentinel Lymph Node Biopsy
8%
Sentinel Node
5%
Surgeon
24%
Surgery
13%
Systemic Therapy
8%
Keyphrases
American College of Surgeons Oncology Group
5%
Axilla
7%
Axillary Lymph Node Dissection
21%
Axillary Surgery
9%
Breast
8%
Breast Cancer
17%
Breast Cancer Patients
29%
Breast Cancer Subtypes
7%
Breast Reconstruction
12%
Breast-conserving Therapy
6%
Clinically Node-negative
13%
Close Margins
5%
Ductal Carcinoma in Situ
10%
Early Breast Cancer
5%
Hormone Receptor
5%
Human Epidermal Growth Factor Receptor 2 (HER2)
7%
Locoregional Recurrence
10%
Mastectomy
10%
Neoadjuvant Chemotherapy
31%
Neoadjuvant Systemic Therapy
5%
Neoadjuvant Therapy
5%
Nodal Disease
8%
Node-positive
8%
Node-positive Breast Cancer
14%
Oncoplastic Breast Surgery
6%
Positive Sentinel Lymph Node
5%
Recurrence-free Survival
7%
Response to Neoadjuvant Chemotherapy
5%
Sentinel Lymph Node
6%
Sentinel Lymph Node Biopsy
7%
Sentinel Lymph Node Dissection
14%
Targeted Axillary Dissection
11%
Triple-negative Breast Cancer
6%
Tumor
7%
Z0011
5%